{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:41:05Z","timestamp":1794397265591,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":26,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642639692","type":"print"},{"value":"9783642594106","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002]]},"DOI":"10.1007\/978-3-642-59410-6_36","type":"book-chapter","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T18:25:15Z","timestamp":1316543115000},"page":"309-320","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of Cutaneous T Cell Lymphoma: 2001"],"prefix":"10.1007","author":[{"given":"Eric C.","family":"Vonderheid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"36_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/archderm.133.5.656","volume":"133","author":"M Baccard","year":"1997","unstructured":"Baccard M, Marolleau JP, Rybojad M (1997) Middle-term evolution of patients with advanced cutaneous T-cell lymphoma treated with high-dose recombinant interleukin-2. Arch Dermatol 133:656.","journal-title":"Arch Dermatol"},{"key":"36_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<304::AID-IJC3>3.0.CO;2-Z","volume":"76","author":"CL Berger","year":"1998","unstructured":"Berger CL, Longley J, Imaeda S, Christensen I, Heald P, Edelson RL (1998) Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor. Int J Cancer 76:304\u2013311.","journal-title":"Int J Cancer"},{"key":"36_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/sj.bmt.1702099","volume":"25","author":"RK Burt","year":"2000","unstructured":"Burt RK, Guitart J, Traynor A, Link C, Rosen S, Pandolfino T, Kuzel TM (2000) Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect. Bone Marrow Transplant 25:111\u2013113.","journal-title":"Bone Marrow Transplant"},{"key":"36_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/archderm.136.6.748","volume":"136","author":"C Clark","year":"2000","unstructured":"Clark C, Dawe RS, Evans AT, Lowe G, Ferguson J (2000) Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol 136:748\u2013752.","journal-title":"Arch Dermatol"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","volume":"19","author":"EC Coninck de","year":"2001","unstructured":"de Coninck EC, Kim YH, Varghese A, Hoppe RT (2001) Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. J Clin Oncol 19:779\u2013784.","journal-title":"J Clin Oncol"},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.V96.9.2987","volume":"96","author":"M-H Delfau-Larue","year":"2000","unstructured":"Delfau-Larue M-H, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M, Bagot M, Farcet J-P (2000) Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 96:2987\u20132992.","journal-title":"Blood"},{"key":"36_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1523-1747.1998.00278.x","volume":"111","author":"FE Fox","year":"1998","unstructured":"Fox FE, Niu Z, Tobia A, Rook AH (1998) Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J Invest Dermatol 111:327\u2013332.","journal-title":"J Invest Dermatol"},{"key":"36_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1523-1747.2000.00830.x","volume":"114","author":"EA Fraser-Andrews","year":"2000","unstructured":"Fraser-Andrews EA, Woolford AJ, Russell-Jones R, Seed PT, Whittaker SJ (2000) Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 114:117\u2013121.","journal-title":"J Invest Dermatol"},{"key":"36_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1046\/j.1523-1747.2000.00980.x","volume":"115","author":"S Gellrich","year":"2000","unstructured":"Gellrich S, Lukowsky A, Schilling T, Rutz S, Muche JM, Jahn S, Audring H, Sterry W (2000) Microanatomical compartments of clonal and reactive T cells in mycosis fungoides: molecular demonstration by single cell polymerase chain reaction of T cell receptor gene rearrangements. J Invest Dermatol 115:620\u2013624.","journal-title":"J Invest Dermatol"},{"key":"36_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","volume":"32","author":"RT Hoppe","year":"1995","unstructured":"Hoppe RT, Medeiros J, Warnke RA, Wood GS (1995) CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 32:448\u2013453.","journal-title":"J Am Acad Dermatol"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0889-8588(18)30058-3","volume":"9","author":"GW Jones","year":"1995","unstructured":"Jones GW, Hoppe RT, Glatstein E (1995) Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:1057\u20131076.","journal-title":"Hematol Oncol Clin North Am"},{"key":"36_CR12","first-page":"276","volume":"26","author":"YH Kim","year":"1999","unstructured":"Kim YH, Hoppe RT (1999) Mycosis fungoides and the Sezary syndrome. Semin Oncol 26:276\u2013289.","journal-title":"Semin Oncol"},{"key":"36_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1634\/stemcells.18-3-220","volume":"18","author":"CJ Link","year":"2000","unstructured":"Link CJ, Seregina T, Traynor A, Burt RK (2000) Cellular suicide therapy of malignant disease. Stem Cells 18:220\u2013226.","journal-title":"Stem Cells"},{"key":"36_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1523-1747.2000.00088.x","volume":"115","author":"J Muche","year":"2000","unstructured":"Muche J, Lukowsky A, Ahnhudt C, Gellrich S, Sterry W (2000) Peripheral blood T cell clonality in mycosis fungoides: an independent prognostic marker J Invest Dermatol 115:504\u2013505.","journal-title":"J Invest Dermatol"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1200\/JCO.2001.19.2.376","volume":"19","author":"E Olsen","year":"2001","unstructured":"Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood G, Gordon M, Heald P, Oseroff A, Pinter-Brown L, Bowen G, Kuzel T, Fivenson D, Foss F, Glode M, Molina A, Knobler E, Stewart S, Cooper K, Stevens S, Craig F, Reuben J, Bacha P, Nichols J (2001) Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 19:367\u2013388.","journal-title":"J Clin Oncol"},{"key":"36_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0190-9622(93)70155-M","volume":"29","author":"KS Resnik","year":"1993","unstructured":"Resnik KS, Vonderheid EC (1993) Home ultraviolet phototherapy of early mycosis fungoides: long-term follow-up observations. J Am Acad Dermatol 29:73\u201377.","journal-title":"J Am Acad Dermatol"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0889-8588(18)30054-6","volume":"9","author":"AH Rook","year":"1995","unstructured":"Rook AH, Heald P (1995) The immunopathogenesis of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:997\u20131010.","journal-title":"Hematol Oncol Clin North Am"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","volume":"94","author":"AH Rook","year":"1999","unstructured":"Rook AH, Wood GS, Yoo EK, Elenitsas R, Kao DMF, Sherman ML, Witmer WK, Rockwell KA, Shane RB, Lessin SR, Vonderheid EC (1999) Interleukin-12 therapy of cutaneous T- cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood 94:902\u2013908.","journal-title":"Blood"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-109-5-372","volume":"109","author":"EA Sausville","year":"1988","unstructured":"Sausville EA, Eddy JL, Makuch RW, Fischmann AB, Schechter GP, Matthews M, Glatstein E, Ihde DC, Kaye F, Veach SR, Phelps R, O\u2019Connor T, Trepel JB, Cotelingam JD, Gazdar AF, Minna JD, Bunn PA Jr (1988) Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome: definition of three distinctive prognostic groups. Ann Intern Med 109:372\u2013382.","journal-title":"Ann Intern Med"},{"key":"36_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1523-1747.1998.00263.x","volume":"111","author":"CP Tensen","year":"1998","unstructured":"Tensen CP, Vermeer MH, van der Stoop PM, van Beek P, Scheper RJ, Boorsma DM, Willemze R (1998) Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol 111:222\u2013226.","journal-title":"J Invest Dermatol"},{"key":"36_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archderm.136.4.504","volume":"136","author":"R Doom van","year":"2000","unstructured":"van Doom R, Van Haselen CW, van Voorst Vader PC, Geerts M-L, Heule F, de Rie M, Steijlen PM, Dekker SK, van Vloten WA, Willemze R (2000) Mycosis fungoides: disease evolution and prognosis in 309 Dutch patients. Arch Dermatol 136:504\u2013510.","journal-title":"Arch Dermatol"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ajcp\/97.1.121","volume":"97","author":"EC Vonderheid","year":"1992","unstructured":"Vonderheid EC, Diamond LW, Lai SM, Au F, Dellavecchia M (1992) Lymph node histopathologic findings in cutaneous T-cell lymphoma. Am J Clin Pathol 97:121\u2013129.","journal-title":"Am J Clin Pathol"},{"key":"36_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1067\/mjd.2002.118538","volume":"46","author":"EC Vonderheid","year":"2002","unstructured":"Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, Olsen E, Pittelkow M, Russell-Jones R, Takigawa M, Willemze R (2002) Update on erythrodermic cutaneous T cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46:95\u2013106.","journal-title":"J Am Acad Dermatol"},{"key":"36_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","volume":"40","author":"LD Wilson","year":"1998","unstructured":"Wilson LD, Kacinski BM, Jones GW (1998) Local superficial radiotherapy in the management of minimal stage la cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys 40:109\u2013115.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"36_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0190-9622(08)81742-2","volume":"31","author":"P Wolf","year":"1994","unstructured":"Wolf P, Fink-Puches R, Cerroni L, Kerl H (1994) Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 31:678\u2013680.","journal-title":"J Am Acad Dermatol"},{"key":"36_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1067\/mjd.2001.110896","volume":"44","author":"C Zane","year":"2001","unstructured":"Zane C, Leali C, Airo P, De Panfilis G, Pinton PC (2001) \u201cHigh-dose\u201d UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 44:629\u2013633.","journal-title":"J Am Acad Dermatol"}],"container-title":["Recent Results in Cancer Research","Cancers of the Skin"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-59410-6_36.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:41:17Z","timestamp":1606171277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-59410-6_36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"ISBN":["9783642639692","9783642594106"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-59410-6_36","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-59410-6","asserted-by":"object"}]},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}